Clik here to view.
Enzyme Linking Fatty Acids to Alpha-synuclein Could Be Parkinson’s...
Inhibiting an enzyme that regulates the production of fatty acids may protect against brain toxicity induced by alpha-synuclein in Parkinson’s disease and may become a therapeutic target for these...
View ArticleClik here to view.
Lewy Bodies Are Made of Much More than Alpha-Synuclein, Study Finds
Insoluble alpha-synuclein protein has long been thought to be the main component of Parkinson’s hallmark Lewy bodies, but researchers have now reported these abnormal aggregates are also made of cell...
View ArticleClik here to view.
New MRI Technique Can Visualize Brain Molecular Composition, Study Shows
A new magnetic resonance imaging (MRI) technique allows for the visualization of molecular changes in the brain, a study reports. This technique will allow researchers to further understand how the...
View ArticleClik here to view.
Imbalance of Fat Content in Brain Cells May Fuel Parkinson’s Progression,...
In patients with Parkinson’s disease, dopamine-producing neurons and microglia cells — the “immune cells” of the brain — accumulate fatty molecules that may promote inflammation and disease...
View ArticleClik here to view.
Changes to Nerve Cell Membrane May Promote Alpha-synuclein’s Toxic Turn
Changes in the composition of fat molecules on the membranes of nerve cells appear to change how the alpha-synuclein protein interacts with these same cell membranes, possibly promoting the aggregation...
View Article
